Louisiana State Employees Retirement System Decreases Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Louisiana State Employees Retirement System cut its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 4.0% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 45,200 shares of the medical equipment provider's stock after selling 1,900 shares during the period. Intuitive Surgical makes up approximately 0.4% of Louisiana State Employees Retirement System's portfolio, making the stock its 25th biggest position. Louisiana State Employees Retirement System's holdings in Intuitive Surgical were worth $23,593,000 at the end of the most recent quarter.

Other hedge funds have also recently made changes to their positions in the company. Bennett Selby Investments LP grew its stake in shares of Intuitive Surgical by 3.9% in the 4th quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider's stock valued at $234,000 after buying an additional 17 shares during the period. LVW Advisors LLC increased its holdings in Intuitive Surgical by 1.3% during the 4th quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider's stock worth $756,000 after purchasing an additional 19 shares in the last quarter. Wesbanco Bank Inc. grew its holdings in shares of Intuitive Surgical by 1.6% in the fourth quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider's stock valued at $635,000 after acquiring an additional 19 shares in the last quarter. FSM Wealth Advisors LLC grew its holdings in shares of Intuitive Surgical by 3.7% in the fourth quarter. FSM Wealth Advisors LLC now owns 526 shares of the medical equipment provider's stock valued at $275,000 after acquiring an additional 19 shares in the last quarter. Finally, Journey Strategic Wealth LLC grew its holdings in shares of Intuitive Surgical by 1.9% in the fourth quarter. Journey Strategic Wealth LLC now owns 1,039 shares of the medical equipment provider's stock valued at $542,000 after acquiring an additional 19 shares in the last quarter. 83.64% of the stock is owned by institutional investors.

Remove Ads

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, CFO Jamie Samath sold 108 shares of the company's stock in a transaction dated Tuesday, November 26th. The shares were sold at an average price of $542.06, for a total value of $58,542.48. Following the transaction, the chief financial officer now directly owns 8,757 shares in the company, valued at $4,746,819.42. This represents a 1.22 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Robert Desantis sold 376 shares of the company's stock in a transaction dated Friday, November 29th. The stock was sold at an average price of $539.00, for a total transaction of $202,664.00. Following the completion of the transaction, the executive vice president now owns 5,506 shares in the company, valued at $2,967,734. This represents a 6.39 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 6,348 shares of company stock worth $3,587,582. Insiders own 0.90% of the company's stock.

Analyst Ratings Changes

Several equities analysts recently commented on the company. Jefferies Financial Group upped their price objective on Intuitive Surgical from $475.00 to $575.00 in a research note on Monday, January 27th. Leerink Partners upped their price objective on Intuitive Surgical from $490.00 to $548.00 in a research note on Monday, January 27th. UBS Group upped their price objective on Intuitive Surgical from $500.00 to $560.00 and gave the company a "neutral" rating in a research note on Monday, January 27th. Truist Financial upped their price objective on Intuitive Surgical from $640.00 to $666.00 and gave the company a "buy" rating in a research note on Friday, January 24th. Finally, Morgan Stanley upgraded Intuitive Surgical from an "equal weight" rating to an "overweight" rating and upped their price objective for the company from $522.00 to $650.00 in a research note on Monday, December 2nd. One analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have issued a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $613.10.

Intuitive Surgical Price Performance

Shares of Intuitive Surgical stock traded up $4.16 during trading hours on Friday, reaching $595.55. The company's stock had a trading volume of 1,188,781 shares, compared to its average volume of 1,979,754. The firm has a 50 day moving average price of $559.48 and a 200-day moving average price of $519.06. Intuitive Surgical, Inc. has a one year low of $364.17 and a one year high of $616.00. The stock has a market cap of $212.12 billion, a P/E ratio of 92.91, a P/E/G ratio of 5.67 and a beta of 1.39.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.